Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Stryker to Acquire Stanmore Implants for $52M BY ANDREW VAHRADIAN, MAY 1, 2016

Stryker entered into an agreement to acquire Stanmore Implants Worldwide Limited in an all cash transaction for £35.6 million ($51.9 million).

Stanmore is an England-based developer of orthopedic implants and solutions for orthopedic adult and juvenile oncology, and complex primary and revision reconstruction cases for upper limb, lower limb and pelvis indications. The company’s product portfolio consists of both patient specific and off-the-shelf (OTS) implant systems targeting limb salvage.

Stryker currently offers modular replacement systems for the hip, femur, knee, and tibia affected by osteosarcoma, however this transaction bolsters Stryker's existing portfolio with differentiated technologies designed to provide specialized solutions for orthopedic oncology surgeons, expanding the company's presence in the marketplace.

At the end of April, Stryker's CEO, Kevin Lobo, remarked that he will not hesitate "to pull the trigger on new deals", and Stanmore is the company's fifth acquisition this year and the first acquisition since this statement. Stryker has executed on two billion plus deals earlier in the year, acquiring Physio-Control, a developer of emergency medical response equipment, and Sage Products, a supplier of disposable health and personal care products. The company has also executed on two tuck-in deals earlier this year including the acquisition of SafeWire, a developer of minimally invasive surgical instruments for spine procedures, and the neurology portfolio of Synergetics USA.

Email this to a colleague: